Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Two San Francisco Startups Sharing In Third Rock’s Rich Third Fund 04/24/14 San Francisco
Kala Pharma Grabs $22.5M More For Eye Drugs 04/23/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
NinePoint Gets $34M From Corning, Others, For Medical Imaging Tech 03/20/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Sage Therapeutics Grabs $38M More For CNS Drugs 03/13/14 Boston
SAGE Therapeutics Lands $38,000,000 Series C Round 03/13/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Voyager Therapeutics Lands $45,000,000 Series A Funding 02/13/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Eleven Prices IPO Below Projected Range, Grabs $50M 02/06/14 Boston
Igenica Lands $14,000,000 Series C Financing Round 01/28/14 San Francisco
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Blueprint Medicines Hauls in $25M For Cancer Drug Push 01/07/14 Boston
Blueprint Medicines Secures $25,000,000 Series B Round 01/07/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Healthcare Gets Personal: The Photos 12/16/13 Boston
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
See You at “Healthcare Gets Personal” on Thursday in Kendall Square 12/11/13 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Editas Medicine Obtains $43,000,000 Series A Financing 11/26/13 Boston
Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders 11/25/13 Boston
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List 11/18/13 National
Page 2 of 12 « previous page · next page »